Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.29 USD | +2.76% | -1.68% | +2.16% |
May. 13 | Liquidia Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.16% | 939M | |
+31.37% | 595B | |
-2.60% | 367B | |
+20.83% | 334B | |
+5.69% | 289B | |
+14.83% | 239B | |
+9.93% | 211B | |
-6.95% | 203B | |
+10.77% | 171B | |
+0.10% | 163B |
- Stock Market
- Equities
- LQDA Stock
- News Liquidia Corporation
- Transcript : Liquidia Corporation Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 11